This receptor has been shown to interact with apoE, a process that is inhibited by RAP. Like LRP, VLDL is expressed within the brain with mutations in the protein leading to neurological disorders.
| Institute |
|---|
| University of Maryland |
| SKU: | 153995 |
|---|---|
| Product description: | The LDLR family is composed of several cell-surface proteins including VLDL. This receptor has been shown to interact with apoE, a process that is inhibited by RAP. Like LRP, VLDL is expressed within the brain with mutations in the protein leading to neurological disorders. |
| Alternate name: | VLDL receptor |
| Conjugation: | Unconjugated |
| Isotype: | IgG1 |
| Molecular weight: | 96 kDa |
| Immunogen: | recombinant sVLDLr1-8 |
| Cat. #: | 153995 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell signaling and signal transduction;Genetics;Neurobiology |
| Application: | WB ; ELISA |
| Target: | Very low density lipoprotein receptor |
| Reactivity: | Human |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | The LDLR family is composed of several cell-surface proteins including VLDL. This receptor has been shown to interact with apoE, a process that is inhibited by RAP. Like LRP, VLDL is expressed within the brain with mutations in the protein leading to neurological disorders. |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Ruiz et al. 2005. J Lipid Res. 46(8):1721-31. PMID: 15863833. The apoE isoform binding properties of the VLDL receptor reveal marked differences from LRP and the LDL receptor. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.